Pliant Therapeutics Inc

NASDAQ:PLRX   3:59:55 PM EDT
16.82
-0.36 (-2.10%)
Other Pre-Announcement

Pliant Therapeutics Provides Corporate Update And Reports Fourth Quarter And Full Year 2020 Financial Results

Published: 03/16/2021 23:08 GMT
Pliant Therapeutics Inc (PLRX) - Pliant Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2020 Financial Results.
Pliant Therapeutics Inc - Pln-74809 Phase 2a Pet Imaging Trial Resumed, With Preliminary Data Expected First Half of 2021.
Pliant Therapeutics Inc - Qtrly Loss per Share $0.54.
Pliant Therapeutics Inc - As of Dec 31, 2020, Had Cash, Equivalents & Short-term Investments of $276.9 Million.
Pliant Therapeutics - Believes It Has Sufficient Funds to Meet Its Operating and Capital Requirements Into 2023.